2022
Exports
$85.8kWorld Rnk 134 / 208
Flag Rnk 443 / 1077
2022
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.38Rnk 75 / 1025
2022
Imports
$845MWorld Rnk 42 / 225
Flag Rnk 5 / 1182
2022
ECONOMIC COMPLEXITY of Nigeria
-1.67Rnk 127 / 133

About

Exports In 2022, Nigeria exported $85.8k in Vaccines, blood, antisera, toxins and cultures, making it the 134th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 443rd most exported product in Nigeria. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Nigeria are: Poland ($18k), Angola ($17.8k), Ireland ($13.6k), Sweden ($10.3k), and China ($7.3k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Nigeria between 2021 and 2022 were Poland ($18k), Angola ($17.8k), and Sweden ($8.3k).

Imports In 2022, Nigeria imported $845M in Vaccines, blood, antisera, toxins and cultures, becoming the 42nd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 5th most imported product in Nigeria. Nigeria imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($515M), United States ($182M), France ($55.4M), India ($36.9M), and Indonesia ($13.6M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Nigeria between 2021 and 2022 were Belgium ($368M), United States ($68.6M), and France ($13.8M).

Latest Trends

Oct 2024

Subnational Monthly Trade

View
Flow
Y-AXIS SCALE

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

The following visualization shows the latest trends on Vaccines, blood, antisera, toxins and cultures. Countries are shown based on data availability.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$85.8k
IMPORTS (2022)$845M
NET TRADE (2022)-$845M

In 2022, Nigeria exported $85.8k in Vaccines, blood, antisera, toxins and cultures. The main destinations of Nigeria exports on Vaccines, blood, antisera, toxins and cultures were Poland ($18k), Angola ($17.8k), Ireland ($13.6k), Sweden ($10.3k), and China ($7.3k).

In 2022, Nigeria imported $845M in Vaccines, blood, antisera, toxins and cultures, mainly from Belgium ($515M), United States ($182M), France ($55.4M), India ($36.9M), and Indonesia ($13.6M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Nigeria WERE (2021 - 2022):
Poland$18k (1%)
Angola$17.8k (1%)
Sweden$8.3k (419%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Nigeria WERE (2021 - 2022):
Cote d'Ivoire-$39.6k (-100%)
Italy-$23.9k (-100%)
United States-$16.1k (-100%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Nigeria's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2022, Nigeria's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALChina+ $42.1k
TOP IMPORT POTENTIALUnited States+ $85.6M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is China. With an export gap of $42.1k.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is United States with an import gap of $85.6M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with